Moreland Mary K's Form 4 filing
Abbott Laboratories (ABT) · filed Mar 3, 2026
- Accession no.
- 0001783147-26-000007
- Filed
- Mar 3, 2026
- Trade date
- Feb 27-Mar 2, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $70.9K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Moreland Mary KCIK 0001783147 | Officer (EXECUTIVE VICE PRESIDENT) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Common shares without par value | FTax withholdingDisposed | −4,630 | $116.26 | −$538,283.8 | 104,904 | Direct | |
| Mar 2, 2026 | Common shares without par value | SSaleDisposed | −613 | $115.58 | −$70,850.54 | 104,291 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.